Side-by-side comparison of AI visibility scores, market position, and capabilities
Cannabis retail POS and compliance management platform for licensed dispensaries, offering inventory tracking, state reporting, and customer management tools. Denver, CO. Raised $25M+.
Flowhub is a Denver, Colorado-based cannabis retail technology company providing point-of-sale and compliance management software to licensed cannabis dispensaries across the United States. Founded in 2015, the company raised over $25 million from investors including Evolent Ventures and others. Flowhub's platform is designed specifically for the compliance requirements of cannabis retail, with deep integrations into state seed-to-sale tracking systems including Metrc, BioTrackTHC, and other state-mandated reporting platforms.\n\nFlowhub's Maui POS system handles the full dispensary transaction workflow including product lookup, age and ID verification, patient or customer record management, transaction processing, and automatic reporting of required data to state compliance systems. The platform also includes inventory management tools that reconcile physical inventory with state-reported quantities, a common pain point for dispensary operators who face significant penalties for compliance discrepancies. Flowhub's Meadow suite adds e-commerce and online menu capabilities for dispensaries that want to offer pre-ordering.\n\nThe cannabis retail technology market has consolidated significantly as the industry matured, with a small number of well-funded platforms capturing the majority of licensed dispensary locations. Flowhub has maintained its position through a focus on compliance reliability and customer support quality, which dispensary operators prioritize given the regulatory stakes of operating in a highly regulated industry. The company competes primarily with Dutchie, Treez, Cova, and other dispensary technology platforms, targeting independent and small-to-mid chain cannabis retailers rather than very large MSO operators.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.